Hydrocortisone vs placebo for severe hospital lung infection
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial studies whether hydrocortisone (a steroid medicine) helps adults with severe bacterial pneumonia that starts in the hospital. Participants get either hydrocortisone or a placebo to see if it improves outcomes in ICU patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a suspected or confirmed bacterial pneumonia that started in the hospital (including ventilator-associated pneumonia)
- You are currently in an intensive care unit (ICU)
- You can sign a consent form, or your legal guardian can sign for you
- Your pneumonia is not from the community or caused by a virus or fungus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common steroid medicines, hydrocortisone and prednisolone, to see which works better for people with severe community-acquired pneumonia. It aims to find the best treatment to help you recover faster.
This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.
This trial tests whether adding the anti-inflammatory drug dexamethasone to standard antibiotics improves recovery from severe hospital-acquired pneumonia in critically ill patients on a ventilator.
This study tests whether giving steroids (a type of anti-inflammatory medicine) to adults hospitalized with severe respiratory infections can help them recover faster. If you have a serious lung infection and low oxygen levels, this trial may be an option for you.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
This trial tests if anti-inflammatory drugs tailored to specific germs can help patients in the ICU with severe community-acquired pneumonia recover faster. You may be eligible if you've been in the ICU less than 48 hours and meet certain diagnostic criteria.
Hear when a new Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.